Product Name | Anti-Human Her2 (Trastuzumab Deruxtecan; T-DXd) |
---|---|
CAS | 1826843-81-5 |
Storage condition | store at -20°C |
Trastuzumab Deruxtecan (Enhertu) is a HER2-targeting ADC combining a humanized anti-HER2 antibody with a topoisomerase I inhibitor, deruxtecan (DXd). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer.
© Copyright 2015-2021 Chemleader Biomedical Co., Ltd. All Rights Reserved.
沪ICP备15046197号-4
沪公网安备31011502007856号
Designed by Kuanersoft